In AML blasts including leukemia stem cells (LSC), the up-regulation of the surface glycoprotein CD200 of immunosuppressive cells is associated with the functional inhibition of natural killer (NK) cells through their receptor CD200R (29, 30). Here, CD200 is linked to acute myeloid leukemia.